Mednet Logo
HomeGynecologic Oncology
Gynecologic Oncology

Gynecologic Oncology

Clinical discussions on gynecologic malignancies, surgical approaches, and multimodal treatment strategies.

Recent Discussions

What is your preferred surgical management of an endometrial cancer with clinically apparent extension to the cervix?

1
2 Answers

Mednet Member
Mednet Member
Gynecologic Oncology · Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center

Given in this scenario with clinically apparent cervical extension and an MRI negative for parametrial involvement, I would want to also ensure the nodes appear normal making the disease consistent with FIGO stage II disease. In this scenario, if the patient does clinically have disease limited to t...

In which circumstances would you offer adjuvant brachytherapy to a surgically staged patient with endometrial cancer if they have received prior pelvic external beam radiation therapy for a non-gynecologic pelvic tumor?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · University of Kentucky

Assuming that adjuvant treatment is clearly indicated based on pathology findings, I would likely offer it, with some caveats. Ideally, the previous RT would have been delivered on an adjuvant basis with a dose of 50 Gy or less to the vaginal cuff area. Rather than the typical 700 cGy x 3 fractions,...

When, if ever, would you perform Her2 testing in serous intraepithelial neoplasia of the endometrium?

1
1 Answers

Mednet Member
Mednet Member
Gynecologic Oncology · Johns Hopkins Medicine - Green Spring Station

It's not known whether HER2 expression or amplification is definitely prognostic for EIN, but I suspect it is and we know it is for stage I uterine serous carcinoma. Seeing HER2 expression in EIN makes me concerned about the possibility of a more aggressive disease. We're currently studying this at ...

What is your approach to the adjuvant treatment for stage IA grade 2 endometrioid adenocarcinoma without LVSI whose molecular classification is p53 abnormal (MMR intact, POLE wild type)?

5
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Varian Medical Systems/Allegheny health network

These attached guidelines recommend consideration of chemo if IA with myometrial invasion. From a radiation perspective, I do brachy alone with consideration of chemotherapy. Concin et al., PMID 33397713

Do you offer surgery for patients with early stage cervical cancer who you suspect will need adjuvant radiation regardless of surgical pathology results?

2 Answers

Mednet Member
Mednet Member
Gynecologic Oncology · Ascension Sacred Heart Cancer Care

Very exophytic tumors in very young women can be treated nicely even if greater than 5 cm without radiation if pet negative and careful patient selection by pelvic exam in my experience.

What are your top takeaways from SGO 2023?

1
7 Answers

Mednet Member
Mednet Member
Gynecologic Oncology · Legacy Health System

There were many great presentations at SGO 2023 along with a few practice changing presentations. Two pivotal randomized phase III clinical trials enrolled advanced, metastatic endometrial cancer patients. Each demonstrated dramatic benefit with the addition of immunotherapy to chemotherapy (followe...

How would you treat a patient with synchronous locally advanced cervical and ovarian cancers?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Varian Medical Systems/Allegheny health network

At a minimum, I would favor removing the ovarian mass and peritoneal and omental bx to get an idea about ovarian cancer (stage 1 or stage III). Based on that, you may start with chemo first (like carbo and taxol) for the ovarian cancer, and assess local response of cervical cancer then definitive ch...

For a patient with IIIC endometrial adenocarcinoma diagnosed and treated with 6 cycles of Carboplatin/Paclitaxel two years prior, would you consider maintenance therapy with PD-L1 inhibition, given results of GY018 and RUBY?

2
2 Answers

Mednet Member
Mednet Member
Gynecologic Oncology · University of Kentucky College of Medicine

Endometrial cancer incidence is increasing in the United States, and very little improvement in survival has been noted for advanced disease until recently. Monotherapy with immune checkpoint inhibitors have offered hope for patients with recurrence, and the recent publication of GY018 and the RUBY ...

What small bowel dose constraints do you use in gyn brachytherapy?

2
3 Answers

Mednet Member
Mednet Member
Radiation Oncology · Varian Medical Systems/Allegheny health network

There is no good outcome data available with this, although some dosimetric studies have limited 2 cc to 60-65 Gy (EQ2). That being said, it is important to monitor at each fraction the closest loop of small bowel and attempts should be made to avoid any hot spots and to spread out that dose to diff...

When do you use a brachytherapy vaginal cuff boost in postoperative cervical cancer treatment?

2
2 Answers

Mednet Member
Mednet Member
Radiation Oncology · Varian Medical Systems/Allegheny health network

I limit use to close or positive margins, or if the patient has had an incidental simple hysterectomy done instead of a radical hysterectomy.